3D Human Periodontal Stem Cells and Endothelial Cells Promote Bone Development in Bovine Pericardium-Based Tissue Biomaterial.
Endothelial Cells differentiation
Runt-related transcription factor 2 (RUNX2)
Vascular Endothelial Growth Factor-A (VEGF-A)
bovine pericardium membrane
human Periodontal Ligament Stem Cells
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
05 Jul 2019
05 Jul 2019
Historique:
received:
03
05
2019
revised:
24
06
2019
accepted:
30
06
2019
entrez:
10
7
2019
pubmed:
10
7
2019
medline:
10
7
2019
Statut:
epublish
Résumé
Bone defects repair represents a public and urgent problem in clinical practice, in fact, every year, more than two million patients required new treatments for bone injuries. Today a complete vascularization is strategic in bone formation, representing a new frontier for clinical application. Aim of this research has been developed a three-dimensional (3D) coculture platform using a bovine pericardium collagen membrane (BioR) loaded with human periodontal ligament stem cells (hPDLSCs) and endothelial differentiated cells from hPDLSCs (E-hPDLSCs) able to undergo toward osteoangiogenesis differentiation process. First, we have characterized at confocal laser scanning microscopy (CLSM) level the E-hPDLSCs phenotype profile, through CD31 and CD34 markers expression and the ability to tube vessel formation. Real Time-Polimerase Chain Reaction (RT-PCR) and western blotting analyses revealed the upregulation of Runt-related transcription factor 2 (RUNX2), Collagen 1A1 (COL1A1), Vascular Endothelial Growth Factor-A (VEGF-A) genes and proteins in the living construct composed by hPDLSCs + E-hPDSCs/BioR. Human PDLSCs + E-hPDLSCs/BioR construct showed also an enhacement of de novo synthesis of osteocalcin. Given that, the extracellular-signal-regulated kinase (ERK)/mitogen activated protein kinase (MAPK) transduction signaling was involved in the osteogenesis and angiogenesis process, the ERK1/2 protein level at biochemical level, in our experimental model, has been investigated. Our results evidenced an upregulation of ERK1/2 proteins level born in the living construct. In conclusion, we believe that the use of the hPDLSCs and E-hPDLSCs coculture togheter with BioR as substrate, could represent an efficient model able to activate through ERK1/2 signaling pathway the osteoangiogenesis process, and then representing a new potential engineered platform for surgeons during the repair and the healing of bone defects.
Identifiants
pubmed: 31284396
pii: ma12132157
doi: 10.3390/ma12132157
pmc: PMC6651787
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Cell Physiol. 1999 Oct;181(1):67-73
pubmed: 10457354
Biochem Biophys Res Commun. 2004 Sep 17;322(2):684-92
pubmed: 15325284
Endocrinology. 2005 Aug;146(8):3428-37
pubmed: 15905316
Am J Physiol Cell Physiol. 2006 Apr;290(4):C1100-8
pubmed: 16371439
Science. 2006 Mar 3;311(5765):1287-90
pubmed: 16439621
Eur Cell Mater. 2008 May 02;15:100-14
pubmed: 18454418
Stem Cells. 2008 Sep;26(9):2408-18
pubmed: 18583536
J Biol Chem. 2010 Nov 19;285(47):36410-9
pubmed: 20851880
Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):637-43
pubmed: 23058014
Tissue Eng Part A. 2013 Dec;19(23-24):2565-76
pubmed: 23799306
Scand J Plast Reconstr Surg Hand Surg. 1990;24(1):13-9
pubmed: 2389116
Cytotechnology. 2016 Mar;68(2):319-29
pubmed: 25698158
J Periodontal Res. 2016 Feb;51(1):112-24
pubmed: 26094874
Cell Signal. 2016 Nov;28(11):1631-41
pubmed: 27478064
Eur Cell Mater. 2016 Sep 16;32:181-201
pubmed: 27633707
J Cell Biochem. 2017 Apr;118(4):819-828
pubmed: 27714895
Front Physiol. 2016 Nov 24;7:559
pubmed: 27932991
Stem Cells Int. 2016;2016:3595941
pubmed: 27999599
J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4):1009-1018
pubmed: 28078846
Stem Cells Int. 2017;2017:5651287
pubmed: 28469672
Stem Cell Res Ther. 2017 May 12;8(1):113
pubmed: 28499402
Cytokine. 2017 Aug;96:261-272
pubmed: 28511117
Eur J Histochem. 2017 May 24;61(2):2791
pubmed: 28735521
FASEB J. 2017 Dec;31(12):5592-5608
pubmed: 28842429
J Biomed Mater Res A. 2018 Jan;106(1):126-137
pubmed: 28879677
Mol Med Rep. 2018 Feb;17(2):2349-2356
pubmed: 29207135
Int J Mol Sci. 2018 Jan 23;19(2):null
pubmed: 29360771
Int J Mol Sci. 2018 Mar 29;19(4):null
pubmed: 29596323
J Cell Physiol. 2018 Oct;233(10):6734-6747
pubmed: 29600566
Stem Cell Res Ther. 2018 Apr 13;9(1):104
pubmed: 29653587
Sci Rep. 2018 Jun 14;8(1):9153
pubmed: 29904155
Int J Nanomedicine. 2018 Jun 29;13:3805-3825
pubmed: 29988728
Front Genet. 2018 Oct 08;9:419
pubmed: 30349553
Sci Rep. 2018 Oct 24;8(1):15749
pubmed: 30356078
Int J Mol Sci. 2018 Dec 06;19(12):null
pubmed: 30563289
J Tissue Eng Regen Med. 2019 Jul;13(7):1109-1121
pubmed: 30942960
Front Physiol. 2019 Apr 30;10:512
pubmed: 31114512
Clin Orthop Relat Res. 1967 Sep-Oct;54:175-85
pubmed: 5589601